PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.70
Bid: 51.70
Ask: 52.10
Change: -1.00 (-1.90%)
Spread: 0.40 (0.774%)
Open: 55.00
High: 55.00
Low: 51.50
Prev. Close: 52.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

Wed, 06th Oct 2021 09:18

(Alliance News) - Shares in IP Group PLC sank on Thursday morning as the company announced a raft of changes to its executive board, triggered by the recent successful float of investee business Oxford Nanopore Technologies Ltd.

Shares in the London-based investor in intellectual property-based businesses were 5.9% lower at 128.80 pence each in London, the worst performer in the FTSE 250 index.

IP Group Chief Executive Alan Aubrey and Chief Investment Officer Mike Townend both will retire from their positions effective immediately.

The news comes after Oxford Nanopore's hugely successful initial public offering on the Main Market of the London Stock Exchange last Thursday, that saw the life sciences business almost reach a GBP5 billion valuation.

The float was a big a win for IP Group, a founding investor in Oxford Nanopore with a 14% stake. The firm made around GBP84 million from the sale of shares but retains a 10% stake in the firm, valued at GBP348.8 million based on the offer price.

Oxford Nanopore was up 1.9% at 578.47p on Wednesday. It had floated at 425p a share last month.

As part of the board reshuffle, IP Group announced that Chief Financial Officer Greg Smith will succeed Aubrey as chief executive, while Chief Operating Officer David Baynes will take on responsibility for finance and become chief financial & operating officer.

"During Alan's tenure as chief executive, the value of the portfolio has increased more than 28-fold to over GBP1.2 billion and has produced several companies worth more than GBP1 billion. We are delighted that Greg will step into the role of chief executive and lead the group in its next phase," commented Chair Douglas Flint.

To help facilitate a handover, both Aubrey and Townend will remain as employees until April 6 and as consultants for a minimum of 12 months from April, IP Group said.

Alan Aubrey said: "Following the successful flotation of Oxford Nanopore Technologies on the London Stock Exchange, this felt a natural moment to step back."

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2021 08:49

IP Group launches share buyback as interim profits surge

(Sharecast News) - Intellectual property-based business developer IP Group said on Thursday that it will launch a £20.0m share buyback after witnessing a rise in interim profits.

Read more
29 Jul 2021 16:00

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
27 Jul 2021 12:07

IP Group's Artios raises USD153 million for cancer therapy pipeline

IP Group's Artios raises USD153 million for cancer therapy pipeline

Read more
27 Jul 2021 09:18

IP Group portfolio company completes Series C financing

(Sharecast News) - Intellectual property-based business investor IP Group said on Tuesday that portfolio company Artios Pharma had completed a $153.0m Series C financing to fund the further development of its clinical-stage pipeline.

Read more
28 Jun 2021 13:41

IN BRIEF: IP Group Non-Exec Director Hynes buys 21,000 shares

IN BRIEF: IP Group Non-Exec Director Hynes buys 21,000 shares

Read more
17 Jun 2021 09:48

IP Group investee Apollo Therapeutics completes USD145 million raise

IP Group investee Apollo Therapeutics completes USD145 million raise

Read more
17 Jun 2021 07:40

IP Group portfolio business raises $145m in financing round

(Sharecast News) - Intellectual property business IP Group said on Thursday that portfolio company Apollo Therapeutics had completed a $145.0m financing round.

Read more
9 Jun 2021 16:08

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
9 Jun 2021 14:27

IN BRIEF: IP Group invests GBP250,000 in GBP1.1 million Itaconix raise

IN BRIEF: IP Group invests GBP250,000 in GBP1.1 million Itaconix raise

Read more
9 Jun 2021 09:21

IN BRIEF: IP Group expects GBP80 million in first half realisations

IN BRIEF: IP Group expects GBP80 million in first half realisations

Read more
9 Jun 2021 08:01

IP Group preparing for first divi as portfolio progress continues

(Sharecast News) - Intellectual property business developer IP Group said on Wednesday that for the year to date, its positive progress made by many of its portfolio companies in 2020 had continued.

Read more
7 Jun 2021 09:24

IP Group sells part of Iksuda Therapeutics stake in financing round

IP Group sells part of Iksuda Therapeutics stake in financing round

Read more
7 Jun 2021 07:25

IP Group portfolio co Iksuda raises £42m to develop cancer drug

(Sharecast News) - Intellectual property business developer IP Group said its portfolio company Iksuda Therapeutics had completed a $42m (£29m) financing round to fund human clinical trials of its lead cancer drug.

Read more
2 Jun 2021 15:55

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
28 May 2021 15:12

IP Group launches joint venture aiming to provide capital in China

IP Group launches joint venture aiming to provide capital in China

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.